Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 27 min ago
Peer-reviewedCC BYJournal for ImmunoTherapy of Cancer

442 Characterization of transcriptomic programs and rare somatic mutations affecting survival and immune checkpoint inhibitor (ICI) response in clear-cell renal cell carcinoma (ccRCC)

  • Sabina Signoretti1
  • Eliezer Van Allen2
  • Ziad Bakouny3
  • Toni K Choueiri4
  • Kevin Meli3
  • Brendan Reardon4
  • Jihye Park5
  • Eddy Saad6
  • Ro Malik7
  • David A Braun8
  • Berkay Simsek1
  • Jad El Masri4
6 more authors
  • Matías Vergara4
  • M Harry Kane7
  • Renee Maria Saliby8
  • Chris Labaki4
  • Valisha Shah4
  • Razan Mohanna4
8 affiliations
  1. 1Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA
  2. 2Aff3 grid.65499.370000000121069910Dana-Farber Cancer Institute Boston MA USA
  3. 31 Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA
  4. 4Dana-Farber Cancer Institute, Boston, MA, USA
  5. 55Dana Farber Cancer Institute, Boston, MA, USA
  6. 61Dana-Farber Cancer Institute, Boston, MA, USA
  7. 7Yale University, New Haven, CT, USA
  8. 8Yale Cancer Center, Yale School of Medicine, New Haven, CT, USA
Open at sourcePDFDOICite

Related

  1. Cancer type-specific profiling of chromatin regulator mutations identifies recurrent and co-occurring gene sets associated with improved survival following immune checkpoint therapy
    D. Bukovec, M. Gjorgjievska, S. Kocevska +5
    medRxivPreprintAll rights reservedFull textOncologymedRxiv
  2. Immune checkpoint inhibitor-associated interstitial nephritis: let’s move forward addressing the unknowns
    Clinical kidney journalPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Beyond Steroids: Mycophenolate Mofetil Dosing in Immune Checkpoint Inhibitor-Mediated Hepatitis
    Shreya Shambhavi, Aksa Alina Joy, Emilia Wilk +1
    Journal of medical casesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Fatal Coronary and Mesenteric Vasculopathy With Immune Checkpoint Inhibitor Therapy
    Aleksandra Abrahamowicz, Roberta Florido, Drew Ferguson +3
    JACC: CardioOncologyPeer-reviewedCC BY 4.0Full textOncologyPMCEurope PMC
  5. 1010 HLA-B allele frequencies in immune checkpoint inhibitor-associated rheumatologic adverse events
    Yinghong Wang, Lily Xu, Yuanteng Jeff Li
    Journal for ImmunoTherapy of CancerPeer-reviewedCC BYFull textOncologyDOAJ

Cite

BibTeXRIS
BibTeX
@article{signoretti2026characterization,
  title = {{442 Characterization of transcriptomic programs and rare somatic mutations affecting survival and immune checkpoint inhibitor (ICI) response in clear-cell renal cell carcinoma (ccRCC)}},
  author = {Sabina Signoretti and Eliezer Van Allen and Ziad Bakouny and Toni K Choueiri and Kevin Meli and Brendan Reardon and Jihye Park and Eddy Saad and Ro Malik and David A Braun and Berkay Simsek and Jad El Masri and Matías Vergara and M Harry Kane and Renee Maria Saliby and Chris Labaki and Valisha Shah and Razan Mohanna},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2026},
  month = nov,
  doi = {10.1136/jitc-2026-sitc2026.0442},
  url = {https://doi.org/10.1136/jitc-2026-sitc2026.0442},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - 442 Characterization of transcriptomic programs and rare somatic mutations affecting survival and immune checkpoint inhibitor (ICI) response in clear-cell renal cell carcinoma (ccRCC)
AU  - Sabina Signoretti
AU  - Eliezer Van Allen
AU  - Ziad Bakouny
AU  - Toni K Choueiri
AU  - Kevin Meli
AU  - Brendan Reardon
AU  - Jihye Park
AU  - Eddy Saad
AU  - Ro Malik
AU  - David A Braun
AU  - Berkay Simsek
AU  - Jad El Masri
AU  - Matías Vergara
AU  - M Harry Kane
AU  - Renee Maria Saliby
AU  - Chris Labaki
AU  - Valisha Shah
AU  - Razan Mohanna
PY  - 2026
DA  - 2026/11/08
JO  - Journal for ImmunoTherapy of Cancer
DO  - 10.1136/jitc-2026-sitc2026.0442
UR  - https://doi.org/10.1136/jitc-2026-sitc2026.0442
SN  - 2051-1426
ER  -